Process View
Any process that stops, prevents or reduces the frequency, rate or extent of response to wounding.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of response to wounding"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
FGFR2 | fibroblast growth factor receptor 2 | 0.992 | ||
VEGFA | vascular endothelial growth factor A | 0.978 | Human | |
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.972 | Human | |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.875 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.850 | Human | |
PSMB7 | proteasome (prosome, macropain) subunit, beta type, 7 | 0.786 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.732 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.682 | Human | |
TBXA2R | thromboxane A2 receptor | 0.662 | Human | |
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.656 | ||
NRP1 | neuropilin 1 | 0.645 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.610 | Human | |
INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.564 | ||
TNF | tumor necrosis factor | 0.553 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.534 | Human | |
PLG | plasminogen | 0.513 | ||
PYCARD | PYD and CARD domain containing | 0.501 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.482 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.456 | Human | |
SYK | spleen tyrosine kinase | 0.418 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.414 | ||
GHR | growth hormone receptor | 0.402 | ||
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.392 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.380 | ||
NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.365 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.364 | ||
PLAU | plasminogen activator, urokinase | 0.354 | Human Mouse | |
PGF | placental growth factor | 0.336 | Human | |
PSMA7 | proteasome (prosome, macropain) subunit, alpha type, 7 | 0.335 | ||
EPOR | erythropoietin receptor | 0.311 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.309 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.298 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.258 | ||
RUNX1 | runt-related transcription factor 1 | 0.245 | ||
PSMB2 | proteasome (prosome, macropain) subunit, beta type, 2 | 0.244 | ||
KNG1 | kininogen 1 | 0.228 | ||
PSMA6 | proteasome (prosome, macropain) subunit, alpha type, 6 | 0.220 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.219 | ||
INADL | InaD-like (Drosophila) | 0.208 | ||
DERL1 | Der1-like domain family, member 1 | 0.201 | ||
PLAT | plasminogen activator, tissue | 0.200 | Human | |
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.195 | ||
DRD2 | dopamine receptor D2 | 0.195 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.192 | Rat | |
APOE | apolipoprotein E | 0.190 | ||
PSMB1 | proteasome (prosome, macropain) subunit, beta type, 1 | 0.189 | ||
FN1 | fibronectin 1 | 0.187 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.180 | ||
C3 | complement component 3 | 0.176 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.176 | ||
PELP1 | proline, glutamate and leucine rich protein 1 | 0.169 | ||
C1QC | complement component 1, q subcomponent, C chain | 0.165 | Human | |
DCN | decorin | 0.162 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.161 | Mouse | |
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.156 | ||
PSMB3 | proteasome (prosome, macropain) subunit, beta type, 3 | 0.153 | ||
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.151 | ||
POMP | proteasome maturation protein | 0.151 | ||
PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.150 | Human | |
ZNF496 | zinc finger protein 496 | 0.148 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.144 | ||
ALB | albumin | 0.141 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.137 | Human | |
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.136 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.132 | ||
C19orf50 | chromosome 19 open reading frame 50 | 0.132 | ||
A2M | alpha-2-macroglobulin | 0.128 | Human | |
RXRA | retinoid X receptor, alpha | 0.125 | ||
SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.123 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.123 | ||
HLA-DMB | major histocompatibility complex, class II, DM beta | 0.120 | ||
PDGFC | platelet derived growth factor C | 0.120 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.115 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.113 | ||
ENG | endoglin | 0.113 | ||
FGF2 | fibroblast growth factor 2 (basic) | 0.113 | ||
MASP2 | mannan-binding lectin serine peptidase 2 | 0.112 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.109 | ||
APOC1 | apolipoprotein C-I | 0.107 | ||
PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.105 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.102 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.101 | ||
C1S | complement component 1, s subcomponent | 0.098 | ||
VCP | valosin containing protein | 0.098 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.095 | ||
COL4A2 | collagen, type IV, alpha 2 | 0.095 | ||
C1R | complement component 1, r subcomponent | 0.094 | ||
MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.093 | ||
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.093 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.092 | ||
PPP2R5B | protein phosphatase 2, regulatory subunit B', beta | 0.088 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.082 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.082 | ||
VWF | von Willebrand factor | 0.079 | ||
APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.076 | ||
GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.076 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.076 | ||
EDF1 | endothelial differentiation-related factor 1 | 0.075 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.075 | ||
HRG | histidine-rich glycoprotein | 0.074 | Mouse | |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.073 | ||
C8B | complement component 8, beta polypeptide | 0.072 | ||
MSR1 | macrophage scavenger receptor 1 | 0.070 | ||
IER2 | immediate early response 2 | 0.069 | ||
C8A | complement component 8, alpha polypeptide | 0.069 | ||
DUSP1 | dual specificity phosphatase 1 | 0.068 | ||
PSMA5 | proteasome (prosome, macropain) subunit, alpha type, 5 | 0.066 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.065 | ||
LCAT | lecithin-cholesterol acyltransferase | 0.065 | ||
F11 | coagulation factor XI | 0.064 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.063 | ||
STAB1 | stabilin 1 | 0.062 | ||
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.062 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.062 | ||
PSMA3 | proteasome (prosome, macropain) subunit, alpha type, 3 | 0.061 | ||
PSMA4 | proteasome (prosome, macropain) subunit, alpha type, 4 | 0.061 | ||
SLX1B | SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) | 0.059 | ||
SDC2 | syndecan 2 | 0.059 | ||
HP | haptoglobin | 0.058 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.058 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.057 | ||
COL5A1 | collagen, type V, alpha 1 | 0.056 | ||
MYH9 | myosin, heavy chain 9, non-muscle | 0.056 | ||
CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.056 | ||
F3 | coagulation factor III (thromboplastin, tissue factor) | 0.054 | ||
IL22 | interleukin 22 | 0.054 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.054 | Mouse | |
OPTN | optineurin | 0.054 | ||
CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.053 | ||
KITLG | KIT ligand | 0.052 | ||
GYPC | glycophorin C (Gerbich blood group) | 0.051 | ||
ITGB1BP3 | integrin beta 1 binding protein 3 | 0.050 | ||
LDLR | low density lipoprotein receptor | 0.050 | ||
SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.050 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.050 | ||
C6 | complement component 6 | 0.050 | ||
MPEG1 | macrophage expressed 1 | 0.049 | ||
PSMA2 | proteasome (prosome, macropain) subunit, alpha type, 2 | 0.049 | ||
SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.049 | ||
THBS1 | thrombospondin 1 | 0.049 | ||
F10 | coagulation factor X | 0.047 | Human | |
WNT2 | wingless-type MMTV integration site family member 2 | 0.047 | ||
COL3A1 | collagen, type III, alpha 1 | 0.046 | ||
PPM1F | protein phosphatase, Mg2+/Mn2+ dependent, 1F | 0.046 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.045 | ||
APBA3 | amyloid beta (A4) precursor protein-binding, family A, member 3 | 0.045 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.045 | ||
FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.045 | ||
MARCO | macrophage receptor with collagenous structure | 0.044 | ||
APOC3 | apolipoprotein C-III | 0.044 | ||
CTGF | connective tissue growth factor | 0.043 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.042 | ||
LIN7A | lin-7 homolog A (C. elegans) | 0.042 | ||
IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.042 | ||
CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.042 | ||
TGFBI | transforming growth factor, beta-induced, 68kDa | 0.042 | ||
ORM1 | orosomucoid 1 | 0.041 | ||
TRADD | TNFRSF1A-associated via death domain | 0.041 | ||
SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 0.041 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.041 | ||
ITGA1 | integrin, alpha 1 | 0.040 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.040 | ||
MSN | moesin | 0.040 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.040 | ||
HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 0.039 | ||
CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.039 | Human | |
DLG1 | discs, large homolog 1 (Drosophila) | 0.039 | ||
CDCP1 | CUB domain containing protein 1 | 0.039 | ||
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.039 | ||
RARA | retinoic acid receptor, alpha | 0.039 | ||
HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.039 | ||
PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 0.039 | ||
ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.038 | ||
CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.037 | ||
CD34 | CD34 molecule | 0.037 | ||
F11R | F11 receptor | 0.037 | ||
APOB | apolipoprotein B (including Ag(x) antigen) | 0.037 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.036 | ||
GADD45B | growth arrest and DNA-damage-inducible, beta | 0.036 | ||
ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.036 | ||
ACTB | actin, beta | 0.036 | ||
CD14 | CD14 molecule | 0.036 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.035 | ||
VTN | vitronectin | 0.035 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.035 | ||
GP9 | glycoprotein IX (platelet) | 0.035 | ||
ADORA2A | adenosine A2a receptor | 0.035 | Mouse | |
CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.035 | ||
APCS | amyloid P component, serum | 0.035 | ||
SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.035 | ||
APOC4 | apolipoprotein C-IV | 0.034 | ||
IGF2R | insulin-like growth factor 2 receptor | 0.034 | ||
ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.034 | ||
GGT5 | gamma-glutamyltransferase 5 | 0.034 | ||
MAP1S | microtubule-associated protein 1S | 0.034 | ||
FGF7 | fibroblast growth factor 7 | 0.034 | Human | |
C2 | complement component 2 | 0.034 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.033 | ||
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.033 | Mouse | |
APP | amyloid beta (A4) precursor protein | 0.033 | ||
RDH16 | retinol dehydrogenase 16 (all-trans) | 0.033 | ||
PLCG1 | phospholipase C, gamma 1 | 0.033 | ||
ANXA2 | annexin A2 | 0.033 | Mouse | |
RPLP2 | ribosomal protein, large, P2 | 0.033 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.033 | Human | |
HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.032 | ||
VEGFC | vascular endothelial growth factor C | 0.032 | Human | |
YAP1 | Yes-associated protein 1 | 0.032 | ||
NCF1 | neutrophil cytosolic factor 1 | 0.032 | ||
THY1 | Thy-1 cell surface antigen | 0.031 | ||
HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.031 | ||
FANCD2 | Fanconi anemia, complementation group D2 | 0.031 | ||
SPP2 | secreted phosphoprotein 2, 24kDa | 0.031 | ||
PDZK1 | PDZ domain containing 1 | 0.031 | ||
IGFBP1 | insulin-like growth factor binding protein 1 | 0.031 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.031 | ||
F2 | coagulation factor II (thrombin) | 0.031 | ||
FOSL2 | FOS-like antigen 2 | 0.031 | ||
THBD | thrombomodulin | 0.031 | ||
PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.030 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.030 | ||
NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.030 | ||
MRC1 | mannose receptor, C type 1 | 0.030 | ||
USPL1 | ubiquitin specific peptidase like 1 | 0.030 | ||
GNMT | glycine N-methyltransferase | 0.030 | ||
ASGR2 | asialoglycoprotein receptor 2 | 0.030 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.029 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.029 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.029 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.029 | Human | |
MAT1A | methionine adenosyltransferase I, alpha | 0.029 | ||
RPS29 | ribosomal protein S29 | 0.029 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.029 | ||
COL1A1 | collagen, type I, alpha 1 | 0.028 | ||
SLC38A3 | solute carrier family 38, member 3 | 0.028 | ||
PKLR | pyruvate kinase, liver and RBC | 0.028 | ||
IGFBP3 | insulin-like growth factor binding protein 3 | 0.028 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.028 | ||
PLTP | phospholipid transfer protein | 0.028 | ||
NNMT | nicotinamide N-methyltransferase | 0.028 | ||
GEM | GTP binding protein overexpressed in skeletal muscle | 0.028 | ||
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.028 | ||
FMOD | fibromodulin | 0.028 | ||
PSMC6 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 | 0.028 | ||
HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.028 | ||
HPN | hepsin | 0.028 | ||
C7 | complement component 7 | 0.028 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.027 | ||
LPA | lipoprotein, Lp(a) | 0.027 | Human | |
ADH6 | alcohol dehydrogenase 6 (class V) | 0.027 | ||
LIPC | lipase, hepatic | 0.027 | ||
NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.027 | ||
EGR2 | early growth response 2 | 0.027 | ||
NGFR | nerve growth factor receptor | 0.027 | ||
FGL1 | fibrinogen-like 1 | 0.027 | ||
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.026 | ||
TUBB6 | tubulin, beta 6 | 0.026 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.026 | ||
SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.026 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.026 | ||
GATA2 | GATA binding protein 2 | 0.026 | Human | |
KLF6 | Kruppel-like factor 6 | 0.026 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.025 | ||
TYROBP | TYRO protein tyrosine kinase binding protein | 0.025 | ||
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.025 | ||
NOV | nephroblastoma overexpressed gene | 0.025 | ||
MLL4 | myeloid/lymphoid or mixed-lineage leukemia 4 | 0.025 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.025 | ||
PRNP | prion protein | 0.025 | ||
VIM | vimentin | 0.025 | ||
PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.025 | ||
FGA | fibrinogen alpha chain | 0.025 | ||
AMN | amnionless homolog (mouse) | 0.025 | ||
COL6A2 | collagen, type VI, alpha 2 | 0.025 | ||
ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 0.025 | ||
ZBTB16 | zinc finger and BTB domain containing 16 | 0.025 | ||
CPN1 | carboxypeptidase N, polypeptide 1 | 0.025 | ||
CYP2A7 | cytochrome P450, family 2, subfamily A, polypeptide 7 | 0.025 | ||
MAGEB18 | melanoma antigen family B, 18 | 0.024 | ||
TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.024 | ||
AFM | afamin | 0.024 | ||
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.024 | ||
PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.024 | ||
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.024 | ||
HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.024 | ||
ANGPTL2 | angiopoietin-like 2 | 0.023 | ||
TMSB4X | thymosin beta 4, X-linked | 0.023 | ||
SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.023 | ||
RPL38 | ribosomal protein L38 | 0.023 | ||
COL14A1 | collagen, type XIV, alpha 1 | 0.023 | ||
PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.023 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.023 | ||
CPB2 | carboxypeptidase B2 (plasma) | 0.023 | Rat | |
GHRL | ghrelin/obestatin prepropeptide | 0.023 | ||
NONO | non-POU domain containing, octamer-binding | 0.023 | ||
CMTM6 | CKLF-like MARVEL transmembrane domain containing 6 | 0.023 | ||
TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.022 | ||
CLEC4G | C-type lectin domain family 4, member G | 0.022 | ||
CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.022 | ||
MMP19 | matrix metallopeptidase 19 | 0.022 | ||
PSMB5 | proteasome (prosome, macropain) subunit, beta type, 5 | 0.022 | ||
F13A1 | coagulation factor XIII, A1 polypeptide | 0.022 | ||
JUNB | jun B proto-oncogene | 0.022 | ||
FGB | fibrinogen beta chain | 0.022 | ||
AMOT | angiomotin | 0.022 | ||
PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.022 | Human | |
NECAB2 | N-terminal EF-hand calcium binding protein 2 | 0.022 | ||
CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.022 | Human | |
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.022 | ||
TJP3 | tight junction protein 3 (zona occludens 3) | 0.022 | ||
ITGB5 | integrin, beta 5 | 0.022 | ||
SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.022 | ||
STAB2 | stabilin 2 | 0.022 | ||
GSTO1 | glutathione S-transferase omega 1 | 0.022 | ||
CDKL5 | cyclin-dependent kinase-like 5 | 0.022 | ||
FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.021 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.021 | ||
HAND2 | heart and neural crest derivatives expressed 2 | 0.021 | ||
CA5A | carbonic anhydrase VA, mitochondrial | 0.021 | ||
FTCD | formiminotransferase cyclodeaminase | 0.021 | ||
AEBP1 | AE binding protein 1 | 0.021 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.021 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.021 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.021 | ||
RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.021 | ||
ESRRG | estrogen-related receptor gamma | 0.021 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.021 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.021 | ||
PRDX4 | peroxiredoxin 4 | 0.021 | ||
CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.020 | ||
CD248 | CD248 molecule, endosialin | 0.020 | ||
TMPRSS6 | transmembrane protease, serine 6 | 0.020 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.020 | ||
GCGR | glucagon receptor | 0.020 | ||
FGFR3 | fibroblast growth factor receptor 3 | 0.020 | ||
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.020 | ||
PRODH2 | proline dehydrogenase (oxidase) 2 | 0.020 | ||
S100A10 | S100 calcium binding protein A10 | 0.020 | ||
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.020 | Human | |
SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.020 | ||
ANXA1 | annexin A1 | 0.020 | ||
ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.020 | ||
LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.020 | ||
HDAC9 | histone deacetylase 9 | 0.020 | ||
BLNK | B-cell linker | 0.020 | ||
THPO | thrombopoietin | 0.020 | ||
SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 | 0.020 | Human Rat | |
PTH1R | parathyroid hormone 1 receptor | 0.019 | ||
CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.019 | ||
UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.019 | ||
SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.019 | ||
VSIG4 | V-set and immunoglobulin domain containing 4 | 0.019 | ||
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.019 | ||
CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.019 | ||
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.019 | ||
C9 | complement component 9 | 0.019 | ||
SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.019 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.019 | ||
HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.019 | Human | |
MRVI1 | murine retrovirus integration site 1 homolog | 0.019 | ||
DPYS | dihydropyrimidinase | 0.019 | ||
NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.019 | ||
STC1 | stanniocalcin 1 | 0.019 | ||
EPB41 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | 0.019 | ||
COMP | cartilage oligomeric matrix protein | 0.019 | Human | |
AMBP | alpha-1-microglobulin/bikunin precursor | 0.019 | ||
PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.019 | ||
ACAN | aggrecan | 0.019 | ||
TGFB2 | transforming growth factor, beta 2 | 0.019 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.019 | ||
ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.019 | ||
PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.019 | Human | |
EMP1 | epithelial membrane protein 1 | 0.019 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.019 | ||
GRB10 | growth factor receptor-bound protein 10 | 0.019 | ||
WISP2 | WNT1 inducible signaling pathway protein 2 | 0.019 | ||
FBLN1 | fibulin 1 | 0.018 | ||
F9 | coagulation factor IX | 0.018 | Human | |
TAT | tyrosine aminotransferase | 0.018 | ||
DERL2 | Der1-like domain family, member 2 | 0.018 | ||
NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.018 | ||
NID1 | nidogen 1 | 0.018 | ||
TFR2 | transferrin receptor 2 | 0.018 | ||
FETUB | fetuin B | 0.018 | ||
FGL2 | fibrinogen-like 2 | 0.018 | ||
AVPR2 | arginine vasopressin receptor 2 | 0.018 | ||
AHSG | alpha-2-HS-glycoprotein | 0.018 | ||
TMEM176B | transmembrane protein 176B | 0.018 | ||
PSMB6 | proteasome (prosome, macropain) subunit, beta type, 6 | 0.018 | ||
MXRA8 | matrix-remodelling associated 8 | 0.018 | ||
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.018 | ||
CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.018 | Human | |
TF | transferrin | 0.018 | ||
RNASE6 | ribonuclease, RNase A family, k6 | 0.018 | ||
SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.018 | ||
KLF2 | Kruppel-like factor 2 (lung) | 0.018 | ||
ENO1 | enolase 1, (alpha) | 0.018 | ||
RPL18 | ribosomal protein L18 | 0.018 | ||
CORO1C | coronin, actin binding protein, 1C | 0.018 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.018 | Zebrafish Mouse | |
IL1R1 | interleukin 1 receptor, type I | 0.018 | ||
SDS | serine dehydratase | 0.018 | ||
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.018 | ||
TXN | thioredoxin | 0.018 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.018 | ||
CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.018 | ||
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.018 | ||
PRDM1 | PR domain containing 1, with ZNF domain | 0.018 | ||
AQP7 | aquaporin 7 | 0.018 | ||
CPN2 | carboxypeptidase N, polypeptide 2 | 0.018 | ||
DAO | D-amino-acid oxidase | 0.017 | ||
KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.017 | ||
LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.017 | ||
AMT | aminomethyltransferase | 0.017 | ||
SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.017 | ||
CFHR2 | complement factor H-related 2 | 0.017 | ||
SFRP1 | secreted frizzled-related protein 1 | 0.017 | ||
CMKLR1 | chemokine-like receptor 1 | 0.017 | ||
ASGR1 | asialoglycoprotein receptor 1 | 0.017 | ||
PTPRE | protein tyrosine phosphatase, receptor type, E | 0.017 | ||
DARC | Duffy blood group, chemokine receptor | 0.017 | ||
SRPX | sushi-repeat containing protein, X-linked | 0.017 | ||
BHMT | betaine--homocysteine S-methyltransferase | 0.017 | ||
WNT11 | wingless-type MMTV integration site family, member 11 | 0.017 | ||
JAK3 | Janus kinase 3 | 0.017 | ||
LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.017 | ||
TFF1 | trefoil factor 1 | 0.017 | ||
SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | 0.017 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.016 | ||
LEPR | leptin receptor | 0.016 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.016 | ||
ECM1 | extracellular matrix protein 1 | 0.016 | ||
SOCS6 | suppressor of cytokine signaling 6 | 0.016 | ||
CD68 | CD68 molecule | 0.016 | ||
ADORA3 | adenosine A3 receptor | 0.016 | ||
PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.016 | ||
CD33 | CD33 molecule | 0.016 | ||
PON1 | paraoxonase 1 | 0.016 | ||
PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.016 | Human Mouse | |
AGXT | alanine-glyoxylate aminotransferase | 0.016 | ||
C5AR1 | complement component 5a receptor 1 | 0.016 | ||
OLFML2B | olfactomedin-like 2B | 0.016 | ||
GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.016 | Human | |
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.016 | ||
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 0.016 | ||
LAMA2 | laminin, alpha 2 | 0.016 | ||
SPHK1 | sphingosine kinase 1 | 0.016 | ||
KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.016 | ||
NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.016 | ||
ARRDC3 | arrestin domain containing 3 | 0.016 | ||
HAP1 | huntingtin-associated protein 1 | 0.016 | ||
C15orf24 | chromosome 15 open reading frame 24 | 0.016 | ||
SLC25A47 | solute carrier family 25, member 47 | 0.016 | ||
SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 0.016 | ||
COL2A1 | collagen, type II, alpha 1 | 0.016 | ||
PVRL3 | poliovirus receptor-related 3 | 0.016 | ||
COL1A2 | collagen, type I, alpha 2 | 0.016 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.016 | ||
ANGPTL3 | angiopoietin-like 3 | 0.016 | ||
CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 | 0.016 | Human | |
AGXT2 | alanine--glyoxylate aminotransferase 2 | 0.016 | ||
MSTO1 | misato homolog 1 (Drosophila) | 0.016 | ||
HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 0.016 | ||
FABP1 | fatty acid binding protein 1, liver | 0.016 | ||
CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.016 | ||
PPIA | peptidylprolyl isomerase A (cyclophilin A) | 0.016 | ||
IGFBP7 | insulin-like growth factor binding protein 7 | 0.016 | ||
PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.016 | ||
HK3 | hexokinase 3 (white cell) | 0.016 | ||
GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.016 | ||
ARHGAP5 | Rho GTPase activating protein 5 | 0.016 | ||
TRIB1 | tribbles homolog 1 (Drosophila) | 0.016 | ||
MAPT | microtubule-associated protein tau | 0.016 | ||
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.015 | Human | |
ADORA1 | adenosine A1 receptor | 0.015 | Mouse Rat | |
G0S2 | G0/G1switch 2 | 0.015 | ||
BGN | biglycan | 0.015 | ||
APOC2 | apolipoprotein C-II | 0.015 | ||
IL12RB2 | interleukin 12 receptor, beta 2 | 0.015 | ||
SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.015 | ||
KLF13 | Kruppel-like factor 13 | 0.015 | ||
TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.015 | ||
COLEC10 | collectin sub-family member 10 (C-type lectin) | 0.015 | ||
MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.015 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.015 | ||
SAA4 | serum amyloid A4, constitutive | 0.015 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.015 | ||
ADAM17 | ADAM metallopeptidase domain 17 | 0.015 | ||
LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.015 | ||
GJB1 | gap junction protein, beta 1, 32kDa | 0.015 | ||
PALM | paralemmin | 0.015 | ||
FCN3 | ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen) | 0.015 | ||
CLIC2 | chloride intracellular channel 2 | 0.015 | ||
FPR3 | formyl peptide receptor 3 | 0.015 | ||
AXL | AXL receptor tyrosine kinase | 0.015 | ||
C4B | complement component 4B (Chido blood group) | 0.015 | ||
EBF2 | early B-cell factor 2 | 0.015 | ||
SGK1 | serum/glucocorticoid regulated kinase 1 | 0.015 | ||
MEN1 | multiple endocrine neoplasia I | 0.015 | ||
SPRY1 | sprouty homolog 1, antagonist of FGF signaling (Drosophila) | 0.015 | ||
LRRC32 | leucine rich repeat containing 32 | 0.015 | ||
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.015 | ||
FMO3 | flavin containing monooxygenase 3 | 0.015 | ||
CETP | cholesteryl ester transfer protein, plasma | 0.015 | ||
HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 0.015 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.015 | ||
SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.015 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.015 | ||
HAS2 | hyaluronan synthase 2 | 0.015 | ||
KLF4 | Kruppel-like factor 4 (gut) | 0.015 | ||
C4BPB | complement component 4 binding protein, beta | 0.015 | ||
ANGPTL4 | angiopoietin-like 4 | 0.015 | ||
F2RL3 | coagulation factor II (thrombin) receptor-like 3 | 0.015 | ||
BANP | BTG3 associated nuclear protein | 0.015 | ||
MEF2A | myocyte enhancer factor 2A | 0.015 | ||
RGS12 | regulator of G-protein signaling 12 | 0.015 | ||
HDAC7 | histone deacetylase 7 | 0.015 | ||
CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.015 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.015 | ||
PZP | pregnancy-zone protein | 0.015 | Human | |
CALCRL | calcitonin receptor-like | 0.015 | Rat | |
GAS6 | growth arrest-specific 6 | 0.014 | ||
LMNA | lamin A/C | 0.014 | ||
C8G | complement component 8, gamma polypeptide | 0.014 | ||
COL6A3 | collagen, type VI, alpha 3 | 0.014 | ||
CD93 | CD93 molecule | 0.014 | ||
CYBA | cytochrome b-245, alpha polypeptide | 0.014 | ||
BTK | Bruton agammaglobulinemia tyrosine kinase | 0.014 | ||
TRIM9 | tripartite motif containing 9 | 0.014 | ||
BAI1 | brain-specific angiogenesis inhibitor 1 | 0.014 | ||
RCN3 | reticulocalbin 3, EF-hand calcium binding domain | 0.014 | ||
PRKCB | protein kinase C, beta | 0.014 | ||
OAF | OAF homolog (Drosophila) | 0.014 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.014 | ||
LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 0.014 | ||
PDCD1 | programmed cell death 1 | 0.014 | ||
PDZD3 | PDZ domain containing 3 | 0.014 | ||
CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.014 | Human | |
GLYAT | glycine-N-acyltransferase | 0.014 | ||
ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.014 | ||
F13B | coagulation factor XIII, B polypeptide | 0.014 | ||
ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.014 | ||
FKBP10 | FK506 binding protein 10, 65 kDa | 0.014 | ||
SLAMF8 | SLAM family member 8 | 0.014 | ||
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.014 | Human | |
INHBA | inhibin, beta A | 0.014 | ||
CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.014 | ||
ACTG1 | actin, gamma 1 | 0.014 | ||
FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.014 | ||
F12 | coagulation factor XII (Hageman factor) | 0.014 | ||
ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.014 | ||
ALOXE3 | arachidonate lipoxygenase 3 | 0.014 | ||
KCNJ5 | potassium inwardly-rectifying channel, subfamily J, member 5 | 0.014 | ||
GPR124 | G protein-coupled receptor 124 | 0.014 | ||
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | 0.014 | ||
PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.014 | ||
ATM | ataxia telangiectasia mutated | 0.014 | ||
C3AR1 | complement component 3a receptor 1 | 0.014 | ||
GREM1 | gremlin 1 | 0.014 | ||
MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.014 | ||
WISP1 | WNT1 inducible signaling pathway protein 1 | 0.014 | ||
LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.014 | ||
EGR3 | early growth response 3 | 0.014 | ||
COL13A1 | collagen, type XIII, alpha 1 | 0.014 | ||
RGS16 | regulator of G-protein signaling 16 | 0.014 | ||
FXYD2 | FXYD domain containing ion transport regulator 2 | 0.014 | ||
PENK | proenkephalin | 0.014 | ||
AADAC | arylacetamide deacetylase (esterase) | 0.014 | ||
CCL16 | chemokine (C-C motif) ligand 16 | 0.013 | ||
MYH11 | myosin, heavy chain 11, smooth muscle | 0.013 | ||
SOD3 | superoxide dismutase 3, extracellular | 0.013 | ||
SFTPB | surfactant protein B | 0.013 | ||
ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.013 | ||
YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.013 | ||
VHL | von Hippel-Lindau tumor suppressor | 0.013 | ||
CLEC3B | C-type lectin domain family 3, member B | 0.013 | ||
WNT1 | wingless-type MMTV integration site family, member 1 | 0.013 | ||
NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.013 | ||
TNC | tenascin C | 0.013 | ||
SHBG | sex hormone-binding globulin | 0.013 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.013 | ||
PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 0.013 | ||
SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 | 0.013 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.013 | ||
FGFR4 | fibroblast growth factor receptor 4 | 0.013 | ||
MMP25 | matrix metallopeptidase 25 | 0.013 | ||
DCTN4 | dynactin 4 (p62) | 0.013 | ||
AP1G1 | adaptor-related protein complex 1, gamma 1 subunit | 0.013 | ||
IL6R | interleukin 6 receptor | 0.013 | ||
SIRPA | signal-regulatory protein alpha | 0.013 | ||
CALCR | calcitonin receptor | 0.013 | ||
MLXIPL | MLX interacting protein-like | 0.013 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.013 | ||
ANPEP | alanyl (membrane) aminopeptidase | 0.013 | ||
ADRA1D | adrenergic, alpha-1D-, receptor | 0.013 | ||
NRP2 | neuropilin 2 | 0.013 | ||
NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.013 | ||
TTR | transthyretin | 0.013 | ||
LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.013 | ||
C4BPA | complement component 4 binding protein, alpha | 0.013 | ||
ABI1 | abl-interactor 1 | 0.013 | ||
LOXL2 | lysyl oxidase-like 2 | 0.013 | ||
HABP2 | hyaluronan binding protein 2 | 0.013 | Human | |
GCKR | glucokinase (hexokinase 4) regulator | 0.013 | ||
TBX2 | T-box 2 | 0.013 | ||
GRM6 | glutamate receptor, metabotropic 6 | 0.013 | ||
PILRA | paired immunoglobin-like type 2 receptor alpha | 0.013 | ||
TREM2 | triggering receptor expressed on myeloid cells 2 | 0.013 | ||
ROM1 | retinal outer segment membrane protein 1 | 0.013 | ||
C10orf72 | chromosome 10 open reading frame 72 | 0.013 | ||
GATA4 | GATA binding protein 4 | 0.013 | Human | |
PTGER1 | prostaglandin E receptor 1 (subtype EP1), 42kDa | 0.013 | Human | |
LEP | leptin | 0.013 | ||
HGFAC | HGF activator | 0.013 | Human | |
FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.013 | Human | |
EPB42 | erythrocyte membrane protein band 4.2 | 0.013 | ||
MVD | mevalonate (diphospho) decarboxylase | 0.013 | ||
HSD17B3 | hydroxysteroid (17-beta) dehydrogenase 3 | 0.013 | ||
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.013 | Mouse | |
CRHBP | corticotropin releasing hormone binding protein | 0.013 | ||
FMO1 | flavin containing monooxygenase 1 | 0.013 | ||
TCF4 | transcription factor 4 | 0.013 | ||
MFAP4 | microfibrillar-associated protein 4 | 0.013 | ||
CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0.013 | ||
TMEM204 | transmembrane protein 204 | 0.013 | ||
SAA1 | serum amyloid A1 | 0.013 | ||
G6PC | glucose-6-phosphatase, catalytic subunit | 0.013 | ||
SOX18 | SRY (sex determining region Y)-box 18 | 0.013 | ||
XBP1 | X-box binding protein 1 | 0.013 | ||
SMAD7 | SMAD family member 7 | 0.013 | ||
RET | ret proto-oncogene | 0.013 | ||
RHBG | Rh family, B glycoprotein (gene/pseudogene) | 0.013 | ||
LBP | lipopolysaccharide binding protein | 0.013 | ||
CRIP2 | cysteine-rich protein 2 | 0.013 | ||
TRPM2 | transient receptor potential cation channel, subfamily M, member 2 | 0.013 | ||
SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.013 | ||
ADM | adrenomedullin | 0.013 | ||
SFRP2 | secreted frizzled-related protein 2 | 0.013 | ||
LIN7C | lin-7 homolog C (C. elegans) | 0.013 | ||
HMOX1 | heme oxygenase (decycling) 1 | 0.013 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.013 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.013 | ||
SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.013 | Mouse | |
PSMA1 | proteasome (prosome, macropain) subunit, alpha type, 1 | 0.013 | Mouse | |
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.012 | ||
CEACAM4 | carcinoembryonic antigen-related cell adhesion molecule 4 | 0.012 | ||
CFD | complement factor D (adipsin) | 0.012 | ||
LTBP2 | latent transforming growth factor beta binding protein 2 | 0.012 | ||
CHRD | chordin | 0.012 | ||
TGFB3 | transforming growth factor, beta 3 | 0.012 | ||
EMILIN2 | elastin microfibril interfacer 2 | 0.012 | ||
SARDH | sarcosine dehydrogenase | 0.012 | ||
SLA | Src-like-adaptor | 0.012 | ||
APOA5 | apolipoprotein A-V | 0.012 | Human | |
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.012 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.012 | ||
WDR18 | WD repeat domain 18 | 0.012 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.012 | ||
FST | follistatin | 0.012 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.012 | Human | |
PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.012 | ||
CPA3 | carboxypeptidase A3 (mast cell) | 0.012 | ||
MCAM | melanoma cell adhesion molecule | 0.012 | ||
ADAP2 | ArfGAP with dual PH domains 2 | 0.012 | ||
ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.012 | ||
CASQ2 | calsequestrin 2 (cardiac muscle) | 0.012 | ||
GPX3 | glutathione peroxidase 3 (plasma) | 0.012 | ||
HAO2 | hydroxyacid oxidase 2 (long chain) | 0.012 | ||
ASPDH | aspartate dehydrogenase domain containing | 0.012 | ||
RGN | regucalcin (senescence marker protein-30) | 0.012 | ||
AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.012 | ||
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.012 | ||
PRRX1 | paired related homeobox 1 | 0.012 | ||
COL16A1 | collagen, type XVI, alpha 1 | 0.012 | ||
MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.012 | ||
TMEM176A | transmembrane protein 176A | 0.012 | ||
IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) | 0.012 | ||
GAB2 | GRB2-associated binding protein 2 | 0.012 | ||
FGF3 | fibroblast growth factor 3 | 0.012 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.012 | ||
DPT | dermatopontin | 0.012 | ||
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.012 | ||
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | 0.012 | ||
PLK2 | polo-like kinase 2 | 0.012 | ||
KCNJ8 | potassium inwardly-rectifying channel, subfamily J, member 8 | 0.012 | ||
MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.012 | ||
ITGAD | integrin, alpha D | 0.012 | ||
CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.012 | ||
AMELX | amelogenin, X-linked | 0.012 | ||
CES1 | carboxylesterase 1 | 0.012 | ||
SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.012 | ||
RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.012 | ||
MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 0.012 | ||
ANGPT2 | angiopoietin 2 | 0.012 | ||
IFT20 | intraflagellar transport 20 homolog (Chlamydomonas) | 0.012 | ||
AGTR1 | angiotensin II receptor, type 1 | 0.012 | ||
MMRN1 | multimerin 1 | 0.012 | ||
EGR1 | early growth response 1 | 0.012 | ||
TNN | tenascin N | 0.012 | ||
ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.012 | ||
CABP2 | calcium binding protein 2 | 0.012 | ||
BCL6B | B-cell CLL/lymphoma 6, member B | 0.012 | ||
GPR27 | G protein-coupled receptor 27 | 0.012 | ||
SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 0.012 | ||
TP53BP1 | tumor protein p53 binding protein 1 | 0.012 | ||
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | 0.012 | ||
SPON2 | spondin 2, extracellular matrix protein | 0.012 | ||
SLC17A3 | solute carrier family 17 (sodium phosphate), member 3 | 0.012 | ||
ADRB3 | adrenergic, beta-3-, receptor | 0.011 | ||
UBB | ubiquitin B | 0.011 | ||
MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.011 | ||
TNNT1 | troponin T type 1 (skeletal, slow) | 0.011 | ||
C19orf60 | chromosome 19 open reading frame 60 | 0.011 | ||
BMP4 | bone morphogenetic protein 4 | 0.011 | ||
UFD1L | ubiquitin fusion degradation 1 like (yeast) | 0.011 | ||
PYDC2 | pyrin domain containing 2 | 0.011 | ||
CD59 | CD59 molecule, complement regulatory protein | 0.011 | ||
SLC18A3 | solute carrier family 18 (vesicular acetylcholine), member 3 | 0.011 | ||
CILP | cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | 0.011 | ||
GPNMB | glycoprotein (transmembrane) nmb | 0.011 | ||
EPHB2 | EPH receptor B2 | 0.011 | ||
AGAP1 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 | 0.011 | ||
COL4A4 | collagen, type IV, alpha 4 | 0.011 | ||
EPHB3 | EPH receptor B3 | 0.011 | ||
ZFPM2 | zinc finger protein, multitype 2 | 0.011 | ||
GNG7 | guanine nucleotide binding protein (G protein), gamma 7 | 0.011 | ||
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.011 | ||
LGMN | legumain | 0.011 | ||
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.011 | ||
APOA2 | apolipoprotein A-II | 0.011 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.011 | ||
RAMP1 | receptor (G protein-coupled) activity modifying protein 1 | 0.011 | ||
STARD8 | StAR-related lipid transfer (START) domain containing 8 | 0.011 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.011 | ||
INHBB | inhibin, beta B | 0.011 | ||
GAB1 | GRB2-associated binding protein 1 | 0.011 | ||
KLF1 | Kruppel-like factor 1 (erythroid) | 0.011 | ||
MAF1 | MAF1 homolog (S. cerevisiae) | 0.011 | ||
LECT2 | leukocyte cell-derived chemotaxin 2 | 0.011 | ||
SDC4 | syndecan 4 | 0.011 | ||
HAMP | hepcidin antimicrobial peptide | 0.011 | ||
SUMO2 | SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) | 0.011 | ||
MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.011 | ||
TAF5L | TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 0.011 | ||
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.011 | Human | |
SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | 0.011 | ||
PCSK6 | proprotein convertase subtilisin/kexin type 6 | 0.011 | ||
HAL | histidine ammonia-lyase | 0.011 | ||
ACTA2 | actin, alpha 2, smooth muscle, aorta | 0.011 | ||
GEMIN4 | gem (nuclear organelle) associated protein 4 | 0.011 |